Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Akihiro Nisiyama
Abstract B02: Heterogeneity of Epithelial-To-Mesenchymal Transition and Resistance Mutation in ALK Inhibitor-Resistant Lung Cancer and Its Circumvention
Related publications
P1.13-07 Epithelial-Mesenchymal Transition Induced the Acquired Resistance to ALK Inhibitor Brigatinib in Lung Cancer Cells Harboring With ALK Fusions
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Triclosan Potentiates Epithelial-To-Mesenchymal Transition in Anoikis-Resistant Human Lung Cancer Cells
PLoS ONE
Multidisciplinary
Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)
International Journal of Oncology
Cancer Research
Oncology
Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
18P Epithelial-To-Mesenchymal Transition (EMT) Is Required for Resistance to Anti-Folate Chemotherapy in Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Overcoming Drug-Tolerant Cancer Cell Subpopulations Showing AXL Activation and Epithelial–mesenchymal Transition Is Critical in Conquering ALK-positive Lung Cancer
Oncotarget
Oncology
The Importance of Epithelial-Mesenchymal Transition and Autophagy in Cancer Drug Resistance
Acquired Tumor Cell Resistance to Sunitinib by Increased Invasion and Epithelial-Mesenchymal Transition in LL/2 Murine Lung Cancer
Oncotarget
Oncology
Commentary on “Epithelial–to–Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer”
Cancer Research
Cancer Research
Oncology
